The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease ...
The World Health Organization (WHO) has strongly recommended CD4 testing as the preferred method for identifying advanced HIV disease among people living with HIV, as part of its newly released 2025 ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback